Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Colin Dinney MD

Colin P. N. Dinney MD

Professor, Division of Surgery; Chairman, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Colin P. N. Dinney is the Chairman of the Department of Urology and a Professor in the Division of Surgery at The University of Texas M. D. Anderson Cancer Center. He is the PI of the M. D. Anderson Genitourinary SPORE in Bladder Cancer Research, which was awarded in September of 2001 and underwent a successful competitive renewal in 2006. In addition to administrating this program, he is actively involved in SPORE-related translational research. His laboratory has been very active in the development of novel therapeutic strategies for bladder cancer, including a major effort on the development of personalized growth-factor-directed and gene therapy. Through his collaborations at UT M. D. Anderson, the NCI, and with industry, Dr. Dinney continues to substantially expand our efforts to develop novel therapies for both early and advanced bladder cancer.